{
    "2018-12-18": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Boeing Is Still among Dow’s Best Performers despite the Sell-Off",
                "features": {
                    "keywords": [
                        "Boeing",
                        "Dow",
                        "Best Performers",
                        "Sell-Off"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "aerospace",
                        "industrial"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-15",
                "original_text": "TLRY Teams Up With Novartis, TLSA To Report Data In Q2, RARX Marches Ahead",
                "features": {
                    "keywords": [
                        "TLRY",
                        "Novartis",
                        "TLSA",
                        "RARX",
                        "Q2",
                        "Data"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "Dow Movers: XOM, BA",
                "features": {
                    "keywords": [
                        "Dow",
                        "Movers",
                        "XOM",
                        "BA"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "energy",
                        "aerospace"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "Pfizer: Recent Developments and Analysts’ Recommendations",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Developments",
                        "Analysts",
                        "Recommendations"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-29",
                "original_text": "Pfizer Invites Public to View and Listen to Webcast of January 29 Conference Call with Analysts",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Webcast",
                        "Conference Call",
                        "Analysts"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-18",
                "original_text": "Health Care Sector Update for 12/18/2018: LXRX, LLY, APHB, JNJ, PFE, ABT, MRK, APHB",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "LXRX",
                        "LLY",
                        "APHB",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "Biotechs Were Innovators In 2018: Here Are The Top New Molecules That Were Approved",
                "features": {
                    "keywords": [
                        "Biotechs",
                        "Innovators",
                        "Top New Molecules",
                        "Approved"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "3 Reasons Why Pfizer's Latest Dividend Hike Is Better Than You Might Think",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Dividend Hike",
                        "Reasons"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "3 Reasons Why Pfizer's Latest Dividend Hike Is Better Than You Might Think",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Dividend Hike",
                        "Reasons"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "Pfizer (PFE) Stock Moves -1.58%: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Stock Moves",
                        "-1.58%"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-10",
                "original_text": "Pfizer's Biosimilar of Avastin Gets Positive CHMP Nod",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Biosimilar",
                        "Avastin",
                        "CHMP Nod"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}